Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating CNTX-4975 for pain in Morton's neuroma has completed. The trial assessed efficacy and safety in subjects with painful intermetatarsal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morton Neuroma

Drugs mentioned

• CNTX-4975

Snippet

Sponsor: Centrexion Therapeutics | Conditions: Painful Intermetatarsal Neuroma (Morton's Neuroma) | Phase 2 | Status: COMPLETED